Jan 15, 20241 min read
Advised a biotechnology unicorn on an aborted acquisition valued at US$ 35 million
Collyer Law advised an American Biotechnology unicorn, specializing in gene therapy, on an aborted acquisition of a Singapore-Based...
Nov 1, 20231 min read
Advising Allozymes on commercial contracts
Collyer Law LLC advised Allozymes Pte. Ltd., a leading biotechnology company leveraging proprietary microfluidics technology for the...
